Huber, Carolin
Krauss, Martin
Reinstadler, Vera
Denicolò, Sara
Mayer, Gert
Schulze, Tobias
Brack, Werner
Oberacher, Herbert
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 27 September 2021
Revised: 26 November 2021
Accepted: 12 January 2022
First Online: 26 January 2022
Declarations
:
: The PROVALID study protocol was approved in each participating country by the responsible local IRB. The analysis of drugs and drug metabolites in urine samples (PROVALID adherence) was further approved by the ethics committee of Innsbruck Medical University (EK Nr. 1235/2019).
: The authors declare no competing interests.